• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Cardiology

Right ventricular structure associated with an increased risk of heart failure and cardiovascular death; (MESA) Right ventricle study

bys25qthea
October 3, 2012
in Cardiology, Chronic Disease
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: PD

Key study points:

1. The presence of right ventricular (RV) hypertrophy, as measured by cardiac MRI, in individuals without cardiovascular disease at baseline, was correlated with an increased risk of heart failure or death due to cardiovascular causes.

 2. This association held even after taking into account left ventricular (LV) hypertrophy.

Primer: It is a truth universally acknowledged that a conversation about cardiovascular risk must include a nod to the left ventricle (LV), whose distress might manifest as chest pain in a patient with LV ischemia, or as increased ECG voltage in a patient with hypertension.  In comparison, the contributions of RV structure and function to cardiovascular disease are not yet well understood. RV morphology was, in fact, dismissed as unimportant in historical animal studies of cardiac function.  However, recent studies of patients with pulmonary hypertension and congestive heart failure have marked RV size and ejection fraction as independent predictors of survival.  Yet, the elucidation of the role of the RV in the community-based patient has proved elusive.

 Background reading:

1. Haddad F, Hunt SA, Rosenthal DN, Murphy DJ. Right ventricular function in cardiovascular disease, parts I and II: anatomy, physiology, aging, and functional assessment of the right ventricle. Circulation. 2008;117:1436–1448, 1717-1731

RELATED REPORTS

Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab reduce postmenopausal fracture risk

Epstein-Barr viral load monitoring reduces risk of post-liver transplant lymphoproliferative disease

Homicide deaths are on the rise for children living in the United States

 2. Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR, Greenland P, Jacob DR Jr, Kronmal R, Liu K, Nelson JC, O’Leary D, Saad MF, Shea S, Szklo M, Tracy RP. Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol. 2002;156:871– 881.

This [prospective cohort] study: In this week’s Circulation, Kawut et al report an analysis of cardiac MRIs and subsequent outcomes in >4000 participants of the Multi-Ethnic Study of Atherosclerosis (MESA): a large prospective study designed to assess risk factors and progression of cardiovascular disease in a sample of healthy patients.  The individuals studied were, on average, mildly overweight, normotensive adults in their early 60’s per baseline data.   Median follow-up time was 5.8 years.

After controlling for demographics, hypertension, smoking status, BMI, and CRP levels, the investigators found that the presence of RV hypertrophy doubled the risk of heart failure and cardiovascular death (hazard ratio, 2.52; p<0.001).  This association held even after accounting for the interaction between RV hypertrophy and LV mass  but was stronger for those patients with lower LV mass. 65% of the study sample had pulmonary function testing approximately two years after baseline.  RV hypertrophy remained significantly associated with heart failure and cardiovascular death even after additionally adjusting for pulmonary disease.

In sum: The presence of RV hypertrophy, as measured by cardiac MRI in patients who were clinically disease-free at baseline, was significantly associated with an increased risk of heart failure or cardiovascular death, even after accounting for LV mass.

Although it is possible that RV hypertrophy may directly contribute to heart failure, the correlation seen in this study does not prove causality.  One very plausible explanation is that RV hypertrophy might be speaking for unmeasured variables that increase both RV afterload and the risk of cardiovascular events; examples include sleep breathing disorders and subclinical pulmonary disease.  Another possibility is that RV hypertrophy might herald an increased risk of heart failure by serving as a very sensitive gauge for LV dysfunction. 

Overall, these provocative results, linking RV structure to cardiovascular disease in community-based patients, serve as a call for further study of possible mechanisms and therapies.

Click to read the study in Circulation 

 Click to read an accompanying editorial in Circulation

  By MP and MS

  © 2012 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. DISCALIMER: Posts are not medical advice and are not intended as such. Please see a healthcare professional if you seek medical advice.

Previous Post

Vitamin D supplementation does not decrease incidence of viral upper respiratory tract infections

Next Post

Health care utilization is higher among patients undergoing liver transplantation for nonalcoholic steatohepatitis (NASH)

RelatedReports

Romosozumab significantly increases bone mineral density in postmenopausal women
Chronic Disease

Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab reduce postmenopausal fracture risk

January 30, 2023
Resection of colorectal liver metastases may improve cost and longevity
Chronic Disease

Epstein-Barr viral load monitoring reduces risk of post-liver transplant lymphoproliferative disease

January 30, 2023
Quick Take: State Gun Laws, Gun Ownership, and Mass Shootings in the US: Cross-Sectional Time Series
Pediatrics

Homicide deaths are on the rise for children living in the United States

January 30, 2023
Ear infections decreasing in infants
Pediatrics

High-protein supplementation improves linear growth in infants

January 30, 2023
Next Post

Health care utilization is higher among patients undergoing liver transplantation for nonalcoholic steatohepatitis (NASH)

Postoperative COX-2 Selective NSAIDs associated with anastomotic leakage following colorectal resection

Beta-blockers are not associated with lower risk of myocardial infarction (MI) or stroke in stable outpatients

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab reduce postmenopausal fracture risk
  • Epstein-Barr viral load monitoring reduces risk of post-liver transplant lymphoproliferative disease
  • Homicide deaths are on the rise for children living in the United States
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options